Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | ACLY | P53396 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | KDM1A | O60341 | 2/20 | 0.44 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.41 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.40 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3738491 | 0.89 | CFTR (0.54) | CFTRKDM4EHSD17B10SMN1; SMN2ALDH1A1 | |
| SCHEMBL9687893 | 0.87 | KDM4E (0.65) | CFTRKDM4EHSD17B10SMN1; SMN2ACLY | |
| SCHEMBL2080103 | 0.86 | ACLY (0.49) | CFTRKDM4EHSD17B10SMN1; SMN2ACLY | |
| SCHEMBL21111044 | 0.84 | ACLY (0.64) | KDM4EHSD17B10ACLYALDH1A1HPGD | |
| SCHEMBL23141175 | 0.84 | CFTR (0.55) | CFTRKDM4EHSD17B10SMN1; SMN2ACLY | |
| SCHEMBL23141176 | 0.82 | ALDH1A1 (0.61) | CFTRKDM4EHSD17B10SMN1; SMN2ACLY | |
| SCHEMBL1450639 | 0.81 | FFAR4 (0.57) | CFTRKDM4EHSD17B10SMN1; SMN2ACLY | |
| SCHEMBL23141173 | 0.80 | KDM1A (0.56) | CFTRKDM4EHSD17B10ACLYALDH1A1 | |
| SCHEMBL5300106 | 0.80 | KDM1A (0.71) | CFTRKDM4EHSD17B10ACLYALDH1A1 | |
| SCHEMBL31518457 | 0.80 | TSHR (0.57) | KDM4EHSD17B10ALDH1A1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10793520-B2 | Sulfonylaminobenzamide compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2020-10-06 | — | — | US | disclosed |
| US-10793520-B2 | Sulfonylaminobenzamide compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2020-10-06 | — | — | US | disclosed |
| US-20190225577-A1 | SULFONYLAMINOBENZAMIDE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2019-07-25 | — | — | US | disclosed |
| US-20190225577-A1 | SULFONYLAMINOBENZAMIDE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2019-07-25 | — | — | US | disclosed |
| EP-3508475-A1 | SULFONYLAMINO BENZAMIDE COMPOUND AND PEST CONTROL AGENT | Nippon Soda Co., Ltd. (JP) | 2019-07-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190225577-A1 | SULFONYLAMINOBENZAMIDE COMPOUND AND PEST CONTROL AGENT | CBR3, CBR1, HRH2 | CFTR 634/4885KDM4E 1440/4885HSD17B10 2066/4885 |
| US-10793520-B2 | Sulfonylaminobenzamide compound and pest control agent | CBR3, CBR1, HRH2 | CFTR 634/4885KDM4E 1440/4885HSD17B10 2066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.